High-yield points
- CNS TB = meningitis, mass lesions and spine. A negative Mantoux (positive in only 19%) doesn't exclude TBM .
- Grade predicts outcome (Palur I–IV):
- mortality 20% → 100% from grade I to IV in the original series ;
- but 45% of grade IV patients still did well after shunting in a later series .
- Hydrocephalus: ETV and shunt perform similarly in children (65% vs 62% success in a randomized trial; no difference on meta-analysis) .
- Stroke is common: 72% at admission, and a quarter more within a month, especially under age 3 and with hydrocephalus .
- Dexamethasone lowers mortality (adults and adolescents) . Thalidomide was associated with response in complicated mass lesions and optochiasmatic arachnoiditis (uncontrolled cohort) .
- Tuberculomas can enlarge paradoxically on treatment.
- Persistent enhancement isn't failure .
- Operate for mass effect from giant tuberculomas , and for diagnostic doubt or abscess (see caveats).
- Pott disease in children: posterior-only surgery works about as well as combined approaches, with less blood loss .
Landmark papers
- Thwaites et al., N Engl J Med 2004: a randomized trial of adjunctive dexamethasone in 545 patients with TBM (aged over 14). It reduced mortality (RR 0.69) but not severe disability .
- Palur et al., J Neurosurg 1991: the clinical grading (I–IV) and grade-based shunting protocol for TBM hydrocephalus. Grade on admission was the only predictor of outcome .
- Aranha et al., Asian J Neurosurg 2018: a randomized trial of ETV vs shunt in 52 children with TBM hydrocephalus, with success 65.4% vs 61.5% .
Tuberculosis of the nervous system takes three main forms:
- tuberculous meningitis (TBM), with hydrocephalus, vasculitis and stroke;
- intracranial mass lesions (tuberculomas and tuberculous abscesses);
- spinal tuberculosis (Pott disease), with cord compression and kyphosis.
Treatment is medical first: antituberculous therapy plus adjunctive anti-inflammatory drugs. The neurosurgeon is called for:
- hydrocephalus;
- mass lesions that need diagnosis or decompression;
- spinal instability or compression.
Tuberculous meningitis in children
- Pediatric cohort (185 children, mean age 53.5 months) :
- at admission: stage I in 36.8%, stage II in 30.8%, stage III in 32.4%;
- positive Mantoux test in only 18.9%, and a BCG scar in 24.3%. A negative skin test doesn't exclude TBM;
- a family history of TB in a third;
- an abnormal chest X-ray in about half.
- Neurosurgical clinical grade (Palur, grades I–IV) :
- this was the only factor that significantly predicted outcome after shunting;
- mortality by grade: 20% (I), 34.7% (II), 51.9% (III), 100% (IV) in the original series.
- Stroke (474 children) :
- 71.5% had stroke at admission (hemiparesis or arterial infarct);
- a further 24.4% of those without it developed stroke within 1 month;
- risk factors: age under 3, convulsions and hydrocephalus.
- Steroids: adjunctive dexamethasone reduced mortality in adolescents and adults (relative risk of death 0.69) in a 545-patient randomized trial .
- It did not reduce severe disability among survivors.
- Corticosteroids are standard in children too (see caveats).
- Thalidomide for complicated CNS TB (38 children) :
- used for TB mass lesions, optochiasmatic arachnoiditis with blindness, spinal cord TB masses and dural lesions;
- 37 of 38 had a satisfactory clinical and radiological response, with no serious toxicity.
Hydrocephalus in TBM
Details are in Management of Hydrocephalus in Bacterial and Viral Meningitis.
- Grade-based approach (Palur) :
- early shunting for grades I–II;
- for grade III, shunt after an EVD trial that improves sensorium, or directly;
- for grade IV, an EVD trial first, shunting only those who improve within 24–48 hours.
- Grade IV isn't hopeless (95 patients, mean age 17.5 years) :
- 45% had a favorable long-term outcome after shunting;
- age over 3 and altered sensorium of 3 days or less predicted a better short-term outcome;
- a failed EVD trial didn't predict worse outcome, so the authors questioned whether a trial is mandatory.
- ETV vs shunt:
- Randomized trial (52 children) :
- success 65.4% with ETV vs 61.5% with shunt;
- ETV failures came early (median 3 days);
- higher TBM grade predicted failure with either (OR 4.2).
- Meta-analysis (369 children) : no significant difference in success, mortality, complications or infection, though wide confidence intervals mean the two can't be called equivalent.
- ETV avoids lifelong shunt dependence and can work even with high CSF protein and communicating hydrocephalus . Basal exudate can make the floor of the third ventricle thick and opaque (see caveats).
Tuberculomas and tuberculous abscesses
- Diagnosis is often presumptive:
- radiological appearance;
- TB elsewhere;
- response to treatment .
- Paradoxical enlargement during treatment is common, and lesions can persist for years .
- Persistent enhancement after 9–12 months of treatment doesn't necessarily mean treatment failure, and most experts don't extend therapy for it alone .
- Surgery:
- stereotactic biopsy when the diagnosis is uncertain (tumor and abscess are in the differential);
- excision or aspiration for a large lesion with mass effect, a tuberculous abscess, or one that fails medical therapy.
- Giant tuberculomas (10 patients) :
- marked T2 hypointensity with perilesional edema;
- craniotomy and excision was the mainstay;
- shunting for hydrocephalus was needed in several patients.
- Adjuncts for enlarging or threatening lesions: corticosteroids, and thalidomide .
Spinal tuberculosis (Pott disease)
- Pattern: anterior vertebral body destruction spreading across the disc, with a paraspinal cold abscess. In children it can produce progressive kyphosis with growth (see caveats).
- Surgery is for neurological deficit, instability, severe or progressive kyphosis, or diagnostic uncertainty (see caveats).
- Approach (systematic review of 9 studies, 247 children with thoracolumbar TB; the comparison came from 2 retrospective studies) :
- posterior-only surgery achieved results equivalent to combined anterior–posterior surgery for kyphosis correction, complications, function and fusion time;
- with less blood loss and shorter operations;
- the evidence is retrospective and heterogeneous.
Related topics
- Management of Hydrocephalus in Bacterial and Viral Meningitis: temporizing, shunting and ETV for postinfectious hydrocephalus.
- Endoscopic Third Ventriculostomy (ETV): technique and outcomes.
- Brain Abscess in Children: the differential for ring-enhancing lesions.
- Arterial Ischemic Stroke in Children: Acute Treatment and Surgery: vasculitic stroke management.
- Epidural Abscess in Children (Intracranial and Spinal): spinal infection and cord compression.
- Fungal Infections of the Central Nervous System: Neurosurgical Implications: the other chronic granulomatous meningitides.
- Intracranial and Spinal Parasitic Infections: Neurosurgical Implications: the differential for cystic and ring-enhancing lesions.
- Encephalitis: Neurosurgical Implications: meningoencephalitis, ICP and decompression.
References
- Güneş A, Uluca Ü, Aktar F, et al. Clinical, radiological and laboratory findings in 185 children with tuberculous meningitis at a single centre and relationship with the stage of the disease. Ital J Pediatr 2015;41:75. doi:10.1186/s13052-015-0186-7. PMID 26467304. verified
- Palur R, Rajshekhar V, Chandy MJ, et al. Shunt surgery for hydrocephalus in tuberculous meningitis: a long-term follow-up study. J Neurosurg 1991;74(1):64–69. doi:10.3171/jns.1991.74.1.0064. PMID 1984509. verified
- Solomons RS, Nieuwoudt ST, Seddon JA, van Toorn R. Risk factors for ischemic stroke in children with tuberculous meningitis. Childs Nerv Syst 2021;37(8):2625–2634. doi:10.1007/s00381-021-05163-2. PMID 33856542. verified
- Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004;351(17):1741–1751. doi:10.1056/NEJMoa040573. PMID 15496623. verified
- van Toorn R, Solomons RS, Seddon JA, Schoeman JF. Thalidomide use for complicated central nervous system tuberculosis in children: insights from an observational cohort. Clin Infect Dis 2021;72(5):e136–e145. doi:10.1093/cid/ciaa1826. PMID 33283220. verified
- Srikantha U, Morab JV, Sastry S, et al. Outcome of ventriculoperitoneal shunt placement in grade IV tubercular meningitis with hydrocephalus: a retrospective analysis in 95 patients. J Neurosurg Pediatr 2009;4(2):176–183. doi:10.3171/2009.3.PEDS08308. PMID 19645554. verified
- Aranha A, Choudhary A, Bhaskar S, Gupta LN. A randomized study comparing endoscopic third ventriculostomy versus ventriculoperitoneal shunt in the management of hydrocephalus due to tuberculous meningitis. Asian J Neurosurg 2018;13(4):1140–1147. doi:10.4103/ajns.AJNS_107_18. PMID 30459883. verified
- Fagundes W, Ahmed AR, Silva YP, et al. Endoscopic third ventriculostomy versus ventriculoperitoneal shunt for treating pediatric tuberculous meningitis hydrocephalus: a systematic review and meta-analysis. J Neurosurg Pediatr 2025;36(3):296–303. doi:10.3171/2025.2.PEDS24441. PMID 40479834. verified
- Marais S, Van Toorn R, Chow FC, et al. Management of intracranial tuberculous mass lesions: how long should we treat for? Wellcome Open Res 2019;4:158. doi:10.12688/wellcomeopenres.15501.3. PMID 32047859. verified
- Swamy SBG, Jaikumar V, Nagaraj NM, et al. Intracranial giant tuberculoma: a 7-year institutional experience and literature review. Clin Neurol Neurosurg 2023;225:107593. doi:10.1016/j.clineuro.2023.107593. PMID 36701938. verified
- Upadhyaya GK, Sami A, Patralekh MK, et al. Surgical management of paediatric thoracolumbar tuberculosis by a combination of anterior and posterior versus posterior only approach: a systematic review and meta-analysis. Global Spine J 2023;13(1):188–196. doi:10.1177/21925682221090478. PMID 35426770. verified
Verification (2026-11-18):
- Each reference's authors, title, journal, year, volume, pages, DOI and PMID were checked on PubMed. Numbers were checked against the PubMed abstracts.
Caveats:
- The following are standard teaching, not drawn from the cited abstracts:
- corticosteroids in children (reference 4 enrolled patients over 14);
- the thickened third-ventricular floor at ETV;
- stereotactic biopsy and excision indications, including surgery for diagnostic doubt or abscess;
- the Pott disease pattern and surgical indications;
- kyphosis progression with growth.
- References 2, 6 and 10 include adults.
- The figure is an original schematic.